Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-13

FDA Approved: XIAFLEX — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Xiaflex (collagenase clostridium histolyticum) submitted by Endo USA, Inc. The approval expands the regulatory autho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XIAFLEX (Collagenase Clostridium histolyticum)

Snippet

SUPPL AP for XIAFLEX (COLLAGENASE CLOSTRIDIUM HISTOLYTICUM)